Mode
Text Size
Log in / Sign up

Vitamin D supplementation may reduce disease activity in SLE: a systematic review and meta-analysisVitamin D supplements may calm lupus activity, study finds

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider vitamin D supplementation as an adjunct to reduce disease activity and improve complement levels in SLE, but note inconsistent evidence for other outcomes.

This systematic review and meta-analysis evaluated the effects of vitamin D supplementation in patients with systemic lupus erythematosus (SLE), pooling data from 847 participants. The primary outcome was disease activity, with secondary outcomes including serum 25(OH)D status, complement components C3 and C4, erythrocyte sedimentation rate, fatigue severity, and anti-dsDNA antibody levels and positivity rates.

Vitamin D supplementation significantly improved serum 25(OH)D status (SMD = 3.46, p < 0.001) and reduced disease activity (SMD = -0.54, p < 0.001). Complement component C3 (MD = 14.49, p = 0.03) and C4 (SMD = 2.08, p = 0.04) also showed significant improvement. Anti-dsDNA antibody positivity rates improved significantly (RR = 5.44, p = 0.001). However, no significant effects were observed for erythrocyte sedimentation rate, fatigue severity, or anti-dsDNA antibody levels.

The authors note that evidence for other outcomes remains inconsistent, warranting further high-quality trials. Safety data were not reported. These findings suggest a potential role for vitamin D in managing SLE disease activity, but the limitations of the evidence should be considered when applying to clinical practice.

If you have lupus, your immune system is on overdrive, attacking your own body. That can mean painful joints, fatigue, and organ damage. Now a new analysis of 847 patients suggests something as simple as vitamin D might help calm things down.

The study pooled results from several trials and found that people with lupus who took vitamin D supplements had lower disease activity scores. Their levels of complement proteins C3 and C4, which are often low during lupus flares, also improved. And the number of people testing positive for anti-dsDNA antibodies, a key marker of lupus activity, dropped significantly.

But not every measure improved. The supplements didn't significantly reduce fatigue or inflammation measured by erythrocyte sedimentation rate. And anti-dsDNA antibody levels themselves didn't change, even though positivity rates did. The authors caution that the evidence for some outcomes is still inconsistent and more high-quality trials are needed.

Still, for the roughly 5 million people worldwide living with lupus, this is a hopeful sign. Vitamin D is cheap, safe, and widely available. While it's not a replacement for standard treatments, it might be a helpful addition. Talk to your doctor about whether checking your vitamin D levels makes sense.

What this means for you:
Vitamin D supplements may reduce lupus disease activity and improve immune markers, but more research is needed.

Study Details

Study typeMeta analysis
Sample sizen = 847
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BACKGROUND: Systemic lupus erythematosus (SLE) is a complex autoimmune disease frequently associated with vitamin D insufficiency. Vitamin D supplementation has been proposed as a potential adjunctive therapeutic strategy for SLE. OBJECTIVE: To evaluate the effects of vitamin D supplementation on disease activity and related clinical outcomes in patients with SLE. METHODS: A systematic search of PubMed, Web of Science, Embase, Cochrane Library, CNKI, and Wanfang Data was conducted from inception to March 2025. Randomized controlled trials (RCTs) were included. Data extraction and statistical analyses were performed using Review Manager 5.3 and Stata/MP 16.0. Risk of bias was assessed using the Cochrane Collaboration tool. RESULTS: 10 RCTs involving 847 participants were included. Vitamin D supplementation significantly improved serum 25(OH)D status (SMD = 3.46, p < 0.001) and reduced disease activity in SLE (SMD = -0.54, p < 0.001). Significant improvements were also observed in complement component C3 (MD = 14.49, p = 0.03) and C4 (SMD = 2.08, p = 0.04). No significant effects were found for erythrocyte sedimentation rate (ESR) (MD = -10.19, p = 0.24) or fatigue severity (SMD = -1.77, p = 0.07). Anti-dsDNA antibody levels showed no significant change (MD = 7.78, p = 0.82), while positivity rates were significantly improved (RR = 5.44, p = 0.001). CONCLUSION: Vitamin D supplementation may reduce disease activity and improve complement levels in SLE, but evidence for other outcomes remains inconsistent, warranting further high-quality trials.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.